Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain

Additional Laboratory Tests to Improve on the Diagnosis of Antiphospholipid Syndrome

(2020) Vittorio Pengo   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Development of New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

(2020) Medha Barbhaiya et al.   ARTHRITIS CARE & RESEARCH

Detection of anti‐domain I antibodies by chemiluminescence enables the identification of high‐risk antiphospholipid syndrome patients: a multicenter multiplatform study

(2019) Dongmei Yin et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome

(2018) Cecilia Beatrice Chighizola et al.   JOURNAL OF AUTOIMMUNITY

Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome

(2017) Teresa Iwaniec et al.   THROMBOSIS RESEARCH

Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome

(2016) A.-S. De Craemer et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome

(2015) Lauro Meneghel et al.   CLINICA CHIMICA ACTA

Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk

(2015) V. Pengo et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

(2015) Laura Andreoli et al.   Arthritis & Rheumatology